ABBVIE, INC.

Biopharmaceutical company

1399 New York Avenue NW Suite 600 Washington DC 20005, Washington, DC  ·  DANIEL BACHNER

Filings
64
Clients
1
Total Income
Years Active
2013–2026

Filings

Year Client Period Income Expenses Doc
2023 ABBVIE INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$830,000
2023 ABBVIE INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$750,000
2023 ABBVIE INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$600,000
2023 ABBVIE INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$1,500,000

Clients Represented

ClientFilingsTotal Income
ABBVIE INC. 64

Lobbyists

NameDisclosed Prior Position
DORCAS ADEKUNLE Legislative Assistant (1/2015-9/2015), Senior Counsel (9/2015-5/2017) and Chief Counsel (5/2017-12/2018) for Representa…
DANIEL BACHNER General Counsel (1/14-11/15): Office of Sen Chris Coons/Sen. Judiciary Cmte-Oversight Subcmte; Counsel (1/13-12/13): Of…
BINTA BEARD 9/2009-9/2010: Legislative Assistant/AAAS Fellow for Rep. Edward J. Markey; 9/2010-4/2014: Legislative Assistant, Senat…
MICHAEL D BOYD Legislative Assistant, Rep. Jim Kolbe
RACHEL DERBY Legislative Correspondent (9/2007-9/2009) for Senator Mel Martinez; Deputy Scheduler/Special Projects Aide (9/2009-8/20…
CATHERINE DRATZ FERGUSON U.S. Senate Finance Committee
JOHN P. FORD Sr.Counsel House Energy&Commerce Com 98-08
ANDREW KAPLAN
HAYDEN RHUDY KENNEDY Sen Orrin Hatch, 1/2011-9/2013 Senior Health Policy Advisor: Sen Mike Enzi, Senate HELP Cmt. 11/2007-1/2011 Research As…
CHRISTOPHER LEIBUNDGUTH
COURTNEY PIRON
CRYSTAL RILEY
STEPHEN SCANGO
HEATHER STRAWN
ADELE R WITENSTEIN